scPharmaceuticals Inc. (SCPH)
USD 2.58
(11.21%)
USD 2.58
(11.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 13.59 Million | - | - | - | - | - |
| Cost of Revenue | 3.81 Million | 468 Thousand | 438 Thousand | 399 Thousand | 364 Thousand | 332 Thousand |
| Gross Profit | 9.78 Million | -468 Thousand | -438 Thousand | -399 Thousand | -364 Thousand | -332 Thousand |
| Operating Expenses | 65.17 Million | 36.15 Million | 25.82 Million | 29.93 Million | 32.9 Million | 29.66 Million |
| Selling, General and Administrative Expenses | 53.36 Million | 20.62 Million | 9.78 Million | 11.78 Million | 8.27 Million | 13.71 Million |
| Research and Development Expenses | 11.8 Million | 15.53 Million | 16.03 Million | 18.14 Million | 24.63 Million | 15.94 Million |
| Other Expenses | - | 1.41 Million | 315 Thousand | -4000.00 | 16 Thousand | -56 Thousand |
| Cost and Expenses | 68.98 Million | 36.15 Million | 25.82 Million | 29.93 Million | 32.9 Million | 29.66 Million |
| Operating Income | -55.39 Million | -36.15 Million | -25.82 Million | -29.93 Million | -32.9 Million | -29.66 Million |
| Interest Expense | 8.12 Million | 3.3 Million | 2.57 Million | 2.58 Million | 1.76 Million | 1.43 Million |
| Income Tax Expense | - | 681 Thousand | 2.45 Million | 2.18 Million | 1.41 Million | -224 Thousand |
| Earnings before Tax | -54.81 Million | -36.83 Million | -28.03 Million | -32.2 Million | -32.99 Million | -29.44 Million |
| Net Income | -54.81 Million | -37.51 Million | -30.48 Million | -34.39 Million | -34.41 Million | -29.44 Million |
| Earnings Per Share Basic | -1.42 | -1.32 | -1.11 | -1.40 | -1.85 | -1.59 |
| Earnings Per Share Diluted | -1.42 | -1.32 | -1.11 | -1.40 | -1.85 | -1.59 |
| Weighted Average Shares Outstanding | 38.51 Million | 28.35 Million | 27.35 Million | 24.56 Million | 18.6 Million | 18.55 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.51 Million | 28.35 Million | 27.35 Million | 24.56 Million | 18.6 Million | 18.55 Million |
| Gross Margin | 0.72 | - | - | - | - | - |
| EBIT Margin | -3.39 | - | - | - | - | - |
| Profit Margin | -4.03 | - | - | - | - | - |
| EBITDA | -46.06 Million | -33.06 Million | -25.02 Million | -29.22 Million | -30.86 Million | -27.67 Million |
| Earnings Before Tax Margin | -4.08 | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 8.05 Million | 6.1 Million | 13.59 Million | 6.09 Million | 3.79 Million | 1.63 Million |
| Cost of Revenue | 2.35 Million | 1.83 Million | 3.81 Million | 1.77 Million | 1.07 Million | 354 Thousand |
| Gross Profit | 5.7 Million | 4.26 Million | 9.78 Million | 4.32 Million | 2.71 Million | 1.28 Million |
| Operating Expenses | 20.13 Million | 20.12 Million | 65.17 Million | 19.58 Million | 17.55 Million | 15.03 Million |
| Selling, General and Administrative Expenses | 17.45 Million | 17.39 Million | - | 16.24 Million | 14.13 Million | 12.09 Million |
| Research and Development Expenses | 2.67 Million | 2.72 Million | - | 3.33 Million | 3.42 Million | 2.93 Million |
| Other Expenses | -1.18 Million | 2.97 Million | 3.6 Million | 2.41 Million | -36 Thousand | 239 Thousand |
| Cost and Expenses | 22.48 Million | 21.95 Million | 68.98 Million | 21.35 Million | 18.63 Million | 15.38 Million |
| Operating Income | -14.43 Million | -15.85 Million | -55.39 Million | -15.25 Million | -14.83 Million | -13.74 Million |
| Interest Expense | 2.13 Million | 2.1 Million | 8.12 Million | 2.09 Million | -2.06 Million | 2.01 Million |
| Income Tax Expense | - | 7724.00 | 458.1 Thousand | -3.48 Million | -272 Thousand | 2.14 Million |
| Earnings before Tax | -17.09 Million | -14.1 Million | -54.81 Million | -13.81 Million | -15.63 Million | -14.15 Million |
| Net Income | -17.09 Million | -14.1 Million | -54.81 Million | -13.81 Million | -15.63 Million | -14.15 Million |
| Earnings Per Share Basic | -0.44 | -0.36 | - | -0.36 | -0.40 | -0.37 |
| Earnings Per Share Diluted | -0.44 | -0.36 | - | -0.36 | -0.40 | -0.37 |
| Weighted Average Shares Outstanding | 38.98 Million | 38.95 Million | 38.51 Million | 38.78 Million | 38.76 Million | 38.69 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.98 Million | 38.95 Million | 38.51 Million | 38.78 Million | 38.76 Million | 38.69 Million |
| Gross Margin | 0.71 | 0.70 | 0.72 | 0.71 | 0.72 | 0.78 |
| EBIT Margin | -1.79 | -2.59 | - | -2.48 | -3.91 | -7.41 |
| Profit Margin | -2.12 | -2.31 | -4.03 | -2.27 | -4.12 | -8.64 |
| EBITDA | -14.37 Million | -15.8 Million | - | -15.11 Million | -14.83 Million | -12.14 Million |
| Earnings Before Tax Margin | -1.79 | -2.60 | -4.08 | -2.50 | -3.91 | -8.39 |
PCPDF
HRB
347850
000521
CWV
PREKF